ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer (BC), defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), which accounts for 15–20% of all BC cases [1].